Monday, January 22, 2018
News: Page (1) of 1 - 07/31/12 Email this story to a friend. email article Print this page (Article printing at page facebook
Bayer earnings down on litigation set-asides
Bayer earnings down on litigation provisions, but revenue up and company raises 2012 outlook
By The Associated Press

BERLIN (AP)  Bayer AG says its second-quarter earnings were a third lower than last year because of one-time charges that included money set aside to deal with litigation linked to a contraceptive, but its revenues rose 10 percent and the company raised its full-year outlook.

The pharmaceutical and chemical company on Tuesday reported net earnings of 494 million ($606 million) for April-June  down from 747 million a year earlier. Revenues climbed to 10.18 billion from 9.25 billion.

Earnings were weighed down by special items totaling 762 million. That included 496 million in risk provisions for "all litigations in connection with the oral contraceptive Yasmin/YAZ of which Bayer is currently aware and which it considers to be worthy of settlement."

Bayer says it is raising its full-year revenue and pre-tax earnings guidance.

Page: 1


Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines